Mandate

Vinge advises Fastighets AB Trianon in connection with its listing on Nasdaq Stockholm

Vinge has advised Fastighets AB Trianon (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.

The prospectus was published on 15 December 2020 and the trading on Nasdaq Stockholm commenced on 17 December 2020.

Vinge’s team primarily consisted of Christian Lindhé, Erik Sjöman, Astrid Isberg and Sophia Reutercrona (Capital markets and public M&A) as well as Anna Edström and Philip Åberg (M&A).

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024